Grants and Resources | COVID-19
| wdt_ID | Grant and Resources | Grant Notice # | Issurer | Location | Link | Purpose | Amount | Qualifiers | Release Date | Notes |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NIH LATE APPLICATION POLICY Due to Public Health Emergency for United States for 2019 Novel Coronavirus (COVID-19) | NOT-OD-20-082 | National Institutes of Health (NIH) | United States | https://grants.nih.gov/grants/guide/notice-files/NOT-OD-20-082.html | It is likely that the emergency declaration related to novel coronavirus (COVID-19) will adversely affect some NIH applicants' and recipients' ability to submit applications in a timely manner. Late applications When delays occur because the applicant or recipient organization is officially closed or unable to submit grant applications due to the effects of COVID-19, the NIH will consider accepting applications late, on a case-by-case basis, in accordance with the NIH Grants Policy Statement, Section 2.3.9, under the following circumstances: Institutions must submit applications or reports as soon as possible after reopening or resuming operations so that grant applications can be submitted, not to exceed the number of days the institution was officially closed or unable to submit grant applications. Institutions must submit a cover letter with the applications with enough detail about the delay so that NIH staff can make a determination whether circumstances justify accepting the application late. Institutions need not request advance permission to submit late due to this declared emergency. NIH will be issuing additional guidance related to this public health emergency in the near future. |
Varies | Related Announcements NOT-OD-20-087 NOT-OD-20-086 NOT-OD-20-083 NOT-OD-20-091 Issued by Office of The Director, National Institutes of Health (OD) |
3/10/2020 | Please direct all inquiries to: Division of Grants Policy Office of Policy for Extramural Research Administration Office of Extramural Research Telephone: 301-435-0949 GrantsPolicy@nih.govand Division of Receipt and Referral Center for Scientific Review Telephone: 301-435-0715 Email: csrdrr@mail.nih.gov |
| 2 | General Frequently Asked Questions (FAQs) - Proposal Submission and Award Management Related to COVID-19 | NOT-OD-20-083 | National Institutes of Health (NIH) | United States | https://grants.nih.gov/grants/guide/notice-files/NOT-OD-20-083.html | FAQs related to NOT-OD-20-087 NOT-OD-20-086 NOT-OD-20-082 NOT-OD-20-091 |
Varies | Varies | 3/10/2020 | Please direct all inquiries to: Division of Grants Policy Office of Policy for Extramural Research Administration Office of Extramural Research Telephone: 301-435-0949 GrantsPolicy@nih.gov |
| 3 | Flexibilities Available to Applicants and Recipients of Federal Financial Assistance Affected by COVID-19 | NOT-OD-20-086 | National Institutes of Health (NIH) | United States | https://grants.nih.gov/grants/guide/notice-files/NOT-OD-20-086.html | To help continue NIH research in the areas affected by COVID-19. The purpose of this Notice is to alert the community of administrative flexibilities that will apply to NIH applicants and recipients. | Varies | Affected entities are those that have been closed, or business activities have been hindered due to COVID-19 precautionary measures and/or illnesses. Entities that are affected will be asked to provide documentation to NIH describing the effects, and how long their facility and NIH related research, clinical practices, or instruction was and/or will be affected. | 3/12/2020 | Please direct all inquiries to: Division of Grants Policy Office of Policy for Extramural Research Administration Office of Extramural Research Telephone: 301-435-0949 GrantsPolicy@nih.gov |
| 4 | Guidance for NIH-funded Clinical Trials and Human Subjects Studies Affected by COVID-19 | NOT-OD-20-087 | National Institutes of Health (NIH) | United States | https://grants.nih.gov/grants/guide/notice-files/NOT-OD-20-087.html | The purpose of this notice is to provide guidance outlining the flexibilities available to recipients conducting NIH-funded clinical trials and human subject studies, that are impacted by the declared public health emergency for COVID-19. | Varies | Recipients will likely encounter delays to ongoing research based on the effects of COVID-19. As outlined in NOT-OD-20-086, recipients may submit late financial and progress reports, if research is delayed due to COVID-19, and may carryover unobligated balances on active grants without requesting prior approval. | 3/16/2020 | Please direct all inquiries to: Division of Grants Policy Office of Policy for Extramural Research Administration Office of Extramural Research Telephone: 301-435-0949 GrantsPolicy@nih.gov |
| 5 | COVID-19 Response Supplement: Tribal Public Health Capacity-Building and Quality Improvement Umbrella Cooperative Agreement. | CDC-RFA-OT18-18020202SUPP20 | Department of Health and Human Services | United States | https://www.grants.gov/web/grants/search-grants.html?keywords=COVID-19 | This is an emergency supplemental funding opportunity announcement in response to the current outbreak of Coronavirus Disease, COVID-19. The purpose of this notice is to announce the availability of emergency supplemental funding to prevent, prepare for, and respond to COVID-19 for the American Indian/Alaska Native (AI/AN) tribal nations and regional AI/AN tribal organizations that were previously awarded funding under Strategy 1 under CDC-RFA-OT18-1803: Tribal Public Health Capacity-Building and Quality Improvement Umbrella Cooperative Agreement. |
Estimated total program funding $$30,000,000 | Native American tribal organizations (other than Federally recognized tribal governments) Native American tribal governments (Federally recognized)Only the American Indian/Alaska Native (AI/AN) tribal nations (>40,000 population) and AI/AN regional tribally designated organizations that were awarded under CDC-RFA-OT18-1803: Tribal Public Health Capacity-Building and Quality Improvement Umbrella Cooperative Agreement are eligible to submit applications under this supplemental NOFO, CDC-RFA-OT18-18030202SUPP20. |
3/24/2020 | Apr 01, 2020 Electronically submitted applications must be submitted no later than 11:59 p.m., ET, on the listed application due date. |
| 6 | Global Health Security through Strengthened Community Based Surveillance | CDC-RFA-GH20-2118 | Department of Health and Human Services Centers for Disease Control - CGH | United States | https://www.grants.gov/web/grants/search-grants.html?keywords=COVID-19 | To expand Integrated Disease Surveillance and Response (IDSR) to the community level. Currently IDSR surveillance with documentation and reporting exist from National, Regional, District to Health Zones. The last level is at the Health Zone or Community Health Post Level. Expansion of IDSR beyond the health zone level will allow documentation | Estimated Funding $25,000,000 | Native American tribal governments (Federally recognized), For profit organizations other than small businesses, Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education, State governments, Public housing authorities/Indian housing authorities, County governments, Private institutions of higher education, Small businesses, City or township governments ,Others (see text field entitled "Additional Information on Eligibility" for clarification), Native American tribal organizations (other than Federally recognized tribal governments), Independent school districts , Public and State controlled institutions of higher education, Special district governments , Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education, Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility" | 3/6/2020 | Close date: May 11, 2020 Electronically submitted applications must be submitted no later than 11:59 p.m., ET, on the listed application due date. |
| 7 | Hospital Association COVID-19 Preparedness and Response Activities | EP-U3R-20-001 | Department of Health and Human Services Assistant Secretary for Preparedness and Response | United States | https://www.grants.gov/web/grants/search-grants.html?keywords=COVID-19 | The purpose of this NOFO is to support the urgent preparedness and response needs of hospitals, health systems, and physicians and nurses on the front lines of the COVID-19 outbreak in order to help prepare them to identify, isolate, assess, transport, and treat patients with or persons under investigation for COVID-19 or other special pathogens.This NOFO will provide targeted awards to 53 hospital associations in all states, the District of Columbia, New York City, and Puerto Rico. | Estimated Total Program Funding: $50,000,000 Award Ceiling: $4,161,693 Award Floor: $106,737 | Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Others (see text field entitled "Additional Information on Eligibility" for clarification) Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education. Eligible entities include 53 hospital associations in all states, the District of Columbia, New York City, and Puerto Rico. |
Mar 24, 2020 last updated Mar 30, 2020 | Apr 03, 2020 All applications will be reviewed on a rolling basis. Link to Additional Information: Hospital Association COVID-19 Preparedness and Response Activities Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact: Grants.gov Contact Center Phone Number: 1-800-518-4726 Hours of operation are 24 hours a day, 7 days a week. The contact center is closed on federal holidays. support@grants.gov Grants.gov Customer Support |
| 8 | EA Research Grants in the Arts, FY2021 | 2020NEA01ORAGRANTS | National Endowment for the Arts | https://www.grants.gov/web/grants/search-grants.html?keywords=CO | The Research Awards application deadline has been extended to help applicants dealing with the effects of COVID-19. | Award Ceiling: $100,000 Award Floor: $10,000 | City or township governments Independent school districts Special district governments Public and State controlled institutions of higher education Private institutions of higher education Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education County governments State governments Native American tribal governments (Federally recognized) |
Posted Date: Jan 17, 2020 Last Updated Date: Mar 24, 2020 | Apr 13, 2020 Research Awards application deadline extension. The Research Awards application deadline has been extended to help applicants dealing with the effects of COVID-19. See the Research Awards guidelines for more information. The Research Awards application deadline has been extended to help applicants dealing with the effects of COVID-19. These are the new dates: Part 1 - Submit to Grants.gov April 13, 2020 by 11:59 p.m., Eastern Time Part 1 deadline has been extended. Part 2 - Submit to Applicant Portal April 16, 2020 at 9:00 a.m., Eastern Time, to April 23, 2020 at 11:59 p.m., Eastern Time Part 2 dates to submit materials have been changed. If you have questions about your application please contact nearesearchgrants@arts.gov | |
| 9 | National Dislocated Worker Grants Program Guidance | ETA-TEGL-12-19 | Department of Labor Employment and Training Administration | United States | https://www.grants.gov/web/grants/search-grants.html?keywords=CO | National Dislocated Worker Grants (DWGs) are discretionary grants awarded by the Secretary of Labor under Section 170 of the Workforce Innovation and Opportunity Act (WIOA) to provide employment-related services for dislocated workers. The Department funds two types of DWGs: Disaster Recovery and Employment Recovery. Disaster Recovery DWGs provide funding to create temporary employment opportunities to assist with clean-up and recovery efforts when an area impacted by an emergency or major disaster is declared eligible for public assistance by the Federal Emergency Management Agency (FEMA), or is declared, or otherwise recognized, as an emergency or disaster of national significance by a Federal agency with authority or jurisdiction over Federal response to the disaster or emergency. Employment Recovery DWGs temporarily expand capacity to serve dislocated workers and to meet the increased demand for employment and training services following a qualifying event. Qualifying events include major economic dislocations, such as plant closures, mass layoffs, or higher-than-average demand for employment and training activities for dislocated members of the Armed Forces and their spouses. Under 20 CFR 687.110(a)(5), the Secretary of Labor may determine other major dislocations eligible for Employment Recovery DWGs. |
Estimated Total Program Funding: $300,000,000 Award Ceiling: $25,000,000 Award Floor: $150,000 | Eligibility varies depending upon the type of National Dislocated Worker Grant requested, as noted below. Please reference the text of TEGL 12-19 for additional requirements. Disaster Recovery DWGs: 1. States, as defined by the Workforce Innovation and Opportunity Act (WIOA) in Section 3(56);2. Outlying areas as defined by WIOA, Section 3(45); and,3. Indian tribal governments as defined by the Stafford Act, 42 U.S.C. 5122(6) Employment Recovery DWGs: 1. a state or outlying area (as defined by WIOA, Section 3), or a consortium of states;2. a local Workforce Development Board (WDB) or a consortium of WDBs;3. an entity eligible for funding through the Indian and Native American program in WIOA Section 166(c);4. entities determined to be appropriate by the governor of the state or outlying area involved; and,5. entities that demonstrate to the Secretary of Labor their capability to effectively respond to circumstances related to particular dislocations. | Mar 19, 2020 | If you have difficulty accessing the full announcement electronically, please contact: Jenifer McEnery Grants Management Specialist McEnery.Jenifer@dol.gov McEnery.Jenifer@dol.gov |
| 10 | CDMRP Peer Reviewed Medical Research Program Technology/Therapeutic Development Award | W81XWH-20-PRMRP-TTDA | Department of Defense Dept. of the Army -- USAMRAA | United States | https://www.grants.gov/web/grants/search-grants.html | The PRMRP Technology/Therapeutic Development Award is a product-driven award mechanism intended to provide support for the translation of promising preclinical findings into products for clinical applications, including prevention, detection, diagnosis, treatment, or quality of life, in at least one of the Congressionally directed FY20 PRMRP Topic Areas. Products in development should be responsive to the healthcare needs of military Service members, Veterans, and/or beneficiaries. The product(s) to be developed may be a tangible item such as a pharmacologic agent (drugs or biologics) or device, or a knowledge-based product. (A “Knowledge Product” is a non-materiel product that addresses an identified need in a Topic Area, is based on current evidence and research, aims to transition into medical practice, training, tools, or to support materiel solutions [systems to develop, acquire, provide, and sustain medical solutions and capabilities], and educates or impacts behavior throughout the continuum of care, including primary prevention of negative outcomes.) The Principal Investigator (PI) must provide a transition plan (including potential funding and resources, see Attachment 8) showing how the product will progress to the next level of development (e.g., clinical trials, delivery to the military or civilian market) after the completion of the PRMRP award. PIs are encouraged to develop relationships with industry and/or other funding agencies to facilitate moving the product into the next phase of development. |
Estimated Total Program Funding: $84,000,000 | Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility" | Posted Date: Feb 28, 2020 Last Updated Date: Mar 30, 2020 | Current Closing Date for Applications: Sep 03, 2020 If you have difficulty accessing the full announcement electronically, please contact: CDMRP Help Desk Phone: 301-682-5507 Email: help@eBRAP.org CDMRP Help Desk |
| 11 | CDMRP Peer Reviewed Medical Research Program Discovery Award | W81XWH-20-PRMRP-DA | Department of Defense Dept. of the Army -- USAMRAA | United States | https://www.grants.gov/web/grants/search-grants.html | The intent of the PRMRP Discovery Award is to support innovative, non-incremental, high-risk/potentially high-reward research that will provide new insights, paradigms, technologies, or applications. Studies supported by this award are expected to lay the groundwork for future avenues of scientific investigation. The proposed research project should include a well-formulated, testable hypothesis based on a sound scientific rationale and study design. Innovation is the most important review criterion. Innovative research may introduce a new paradigm, look at existing problems from new perspectives, or exhibit other highly creative qualities. Research that represents an incremental advancement on previously published work is not considered innovative. The following list, although not all-inclusive, provides examples of research that is not innovative: • Using a published series of in vitro assays to further characterize a model system • Incorporating known biomarkers into in vivo or clinical models of the disease or condition • Investigating the next logical step or continuation of a previous research project • Proposing work that is an incremental advancement of published data Inclusion of preliminary data is not required, but is allowed. The strength of the proposed research should be based on sound scientific rationale and logical reasoning. The presentation of substantial preliminary data suggests that the proposed research project would be more appropriately submitted to a different award mechanism. The outcome of research supported by this award should be the generation of robust preliminary data that can be used as a foundation for future research projects. Absence of preliminary data will not negatively affect scientific or programmatic review of the application. Early career investigators, including postdoctoral fellows (or equivalent), are encouraged to be named by the organization as the Principal Investigator (PI) on the application. Reviewers at both tiers of review will be blinded to the identity of the PI, collaborator(s), and their organization(s). Due to the blinded nature of the review process, identifying or making references to the PI, collaborator(s), or their organization(s) in certain components of the application is prohibited and will result in administrative rejection of the application. Refer to Section II.D.2.b.i, Full Application Guidelines, for more information. A document describing common blinding mistakes to avoid can be found on the eBRAP “Funding Opportunities & Forms” web page (https://ebrap.org/eBRAP/public/Program.htm). |
Estimated Total Program Funding: $22,500,000 | Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility" | Posted Date: Feb 28, 2020 Last Updated Date: Mar 30, 2020 | Current Closing Date for Applications: May 21, 2020 If you have difficulty accessing the full announcement electronically, please contact: CDMRP Help Desk Phone: 301-682-5507 Email: help@eBRAP.org CDMRP Help Desk |
| 12 | CDMRP Peer Reviewed Medical Research Program Focused Program Award | W81XWH-20-PRMRP-FPA | Department of Defense Dept. of the Army -- USAMRAA | United States | https://www.grants.gov/web/grants/search-grants.html | The PRMRP Focused Program Award mechanism is intended to optimize research and accelerate solutions to a critical question related to at least one of the Congressionally directed FY20 PRMRP Topic Areas through a synergistic, multidisciplinary research program. | Estimated Total Program Funding: $43,200,000 | Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility" | Posted Date: Feb 28, 2020 Last Updated Date: Mar 30, 2020 | Current Closing Date for Applications: Aug 13, 2020 If you have difficulty accessing the full announcement electronically, please contact: CDMRP Help Desk Phone: 301-682-5507 Email: help@eBRAP.org CDMRP Help Desk |
| 13 | CDMRP Peer Reviewed Medical Research Program Investigator-Initiated Research Award | W81XWH-20-PRMRP-IIRA | Department of Defense Dept. of the Army -- USAMRAA | United States | https://www.grants.gov/web/grants/search-grants.html | he PRMRP Investigator-Initiated Research Award is intended to support studies that will make an important contribution toward research and/or patient care for a disease or condition related to at least one of the FY20 PRMRP Topic Areas. | Estimated Total Program Funding: $93,000,000 | Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility" | Posted Date: Feb 28, 2020 Last Updated Date: Mar 30, 2020 | If you have difficulty accessing the full announcement electronically, please contact: CDMRP Help Desk Phone: 301-682-5507 Email: help@eBRAP.org CDMRP Help Desk |
| 14 | Strengthening Regional Field Epidemiology Training Program (FETP) Networks | CDC-RFA-GH20-2131 | Department of Health and Human Services Centers for Disease Control - CGH | United States | https://www.grants.gov/web/grants/search-grants.html | Development of a well-trained epidemiologic public health workforce in surveillance, outbreak detection and response is essential in meeting Global Health Security objectives. In partnership with Ministries of Health and other public and private stakeholders, CDC seeks to accelerate progress toward a world safe and secure from infectious disease threats by building workforce capacity through creation and support of regional networks of field epidemiology and training programs (FETPs). | Estimated Total Program Funding: $500,000,000 | Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education For profit organizations other than small businesses State governments Small businesses Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Others (see text field entitled "Additional Information on Eligibility" for clarification) Native American tribal organizations (other than Federally recognized tribal governments) County governments Special district governments Public housing authorities/Indian housing authorities Private institutions of higher education City or township governments Independent school districts Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility" Native American tribal governments (Federally recognized) Public and State controlled institutions of higher education This is an open competition NOFO. |
Mar 04, 2020 | May 04, 2020 Electronically submitted applications must be submitted no later than 11:59 p.m., ET, on the listed application due date. If you have difficulty accessing the full announcement electronically, please contact: Herbert Kimble cwz2@cdc.gov Grants Policy |
| 15 | Global Health Security Partnerships: Expanding and Improving Public Health Laboratory Strategies and Systems. | CDC-RFA-GH20-2109 | Department of Health and Human Services Centers for Disease Control - CGH | United States | https://www.grants.gov/web/grants/search-grants.html | This Notice of Funding Opportunity is to continue to support the implementation and expansion of programs and activities previously funded under CDC-RFA-GH15-1632 that focus on protecting and improving public health globally by building or strengthening public health laboratory capacity to: 1) prevent avoidable epidemics by promoting evidence-based policies and decision making; 2) detect threats early by improving surveillance systems; strengthen laboratory systems to detect, differentiate, and characterize pathogens; train field epidemiologists whose data analysis informs evidence-based policy; investigate outbreaks, and conduct event-based surveillance; and 3) respond effectively to infectious disease threats by creating interconnected robust public health emergency management programs, including emer | Estimated Total Program Funding: $175,000,000 | Public and State controlled institutions of higher education Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility" Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Small businesses Native American tribal organizations (other than Federally recognized tribal governments) Special district governments Independent school districts For profit organizations other than small businesses County governments Native American tribal governments (Federally recognized) Others (see text field entitled "Additional Information on Eligibility" for clarification) Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Private institutions of higher education City or township governments State governments Public housing authorities/Indian housing authorities This is an open competition NOFO. |
Mar 03, 2020 | May 04, 2020 Electronically submitted applications must be submitted no later than 11:59 p.m., ET, on the listed application due date If you have difficulty accessing the full announcement electronically, please contact: Herbert Kimble cwz2@cdc.gov Grants Policy |
| 16 | Building Capacity for National Public Health Institutes | CDC-RFA-GH20-2107 | Department of Health and Human Services Centers for Disease Control - CGH | United States | https://www.grants.gov/web/grants/search-grants.html | Consolidating and organizing public health expertise and systems within a National Public Health Institute (NPHI) is a successful way for countries to carry out essential public health functions and improve their accountability and efficiency. The CDC, with over 70 years of experience as the U.S. NPHI, is helping countries around the world increase surveillance, laboratory, and outbreak response capacity to improve recognition of and response to health threats. An NPHI coupled with stronger local outbreak detection a | Estimated Total Program Funding: $150,000,000 Award Ceiling: $3,000,000 | Small businesses Independent school districts Public housing authorities/Indian housing authorities Others (see text field entitled "Additional Information on Eligibility" for clarification) City or township governments Special district governments Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Native American tribal organizations (other than Federally recognized tribal governments) Private institutions of higher education For profit organizations other than small businesses State governments County governments Native American tribal governments (Federally recognized) Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility" Public and State controlled institutions of higher education This is an open competition NOFO. |
Mar 02, 2020 | May 04, 2020 Electronically submitted applications must be submitted no later than 11:59 p.m., ET, on the listed application due date. If you have difficulty accessing the full announcement electronically, please contact: Dennis Jaris Djarvis@cdc.gov Grants Policy |
| 17 | Enhancing Global Health Security: Expanding Efforts and Strategies to Protect and Improve Public Health Globally | CDC-RFA-GH20-2110 | Department of Health and Human Services Centers for Disease Control - CGH | United States | https://www.grants.gov/web/grants/search-grants.html | This Notice of Funding Opportunity (NOFO) seeks to build upon activities funded by CDC to support Global Health Security (GHS) through implementation of programs and activities that focus on protecting and improving health globally through partnerships with Ministries of Health and other governmental institutions. After five years of implementing and strengthening global health security systems, the USG will continue to advance prevent, detect, and respond strategies to mitigate threats. This NOFO’s main outcomes are to: Improve prevention of avoidable epidemics including naturally occurring outbreaks and intentional or accidental releases of dangerous pathogens Improve ability to rapidly detect threats early, including detecting, characterizing, and r |
Estimated Total Program Funding: $500,000,000 | Public and State controlled institutions of higher education Special district governments Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Public housing authorities/Indian housing authorities Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education State governments For profit organizations other than small businesses Independent school districts Small businesses Private institutions of higher education County governments Native American tribal organizations (other than Federally recognized tribal governments) City or township governments Others (see text field entitled "Additional Information on Eligibility" for clarification) Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility" Native American tribal governments (Federally recognized) Additional Information on Eligibility: This is an open competition NOFO |
Posted Date: Feb 27, 2020 Last Updated Date: Mar 09, 2020 | Apr 27, 2020 Electronically submitted applications must be submitted no later than 11:59 p.m., ET, on the listed application due date. |
| 18 | Strengthening Global Field Epidemiology Training Program (FETP) Network | CDC-RFA-GH20-2108 | Department of Health and Human Services Centers for Disease Control - CGH | United States | https://www.grants.gov/web/grants/search-grants.html | Globally there is insufficient capacity to adequately prevent, detect and respond to public health issues. Field epidemiology networks have been assisting countries with developing and strengthening their public health workforce and are essential to strengthening health systems worldwide and achieving global public health objectives. The purpose of this announcement is to partner with an established Global Network and at least two established Regional Networks of public health training in target regions (Sub-Saharan Africa and Asia Pacific) to strengthen and sustain applied epidemiology | Estimated Total Program Funding: $500,000,000 | For profit organizations other than small businesses County governments Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education State governments Special district governments Small businesses Native American tribal organizations (other than Federally recognized tribal governments) City or township governments Native American tribal governments (Federally recognized) Others (see text field entitled "Additional Information on Eligibility" for clarification) Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Public and State controlled institutions of higher education Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility" Public housing authorities/Indian housing authorities Independent school districts Private institutions of higher education Additional Information on Eligibility: This is an open competition NOFO |
Feb 27, 2020 | Apr 27, 2020 Electronically submitted applications must be submitted no later than 11:59 p.m., ET, on the listed application due date. If you have difficulty accessing the full announcement electronically, please contact: Herbert Kimble CWZ2@cdc.gov Grants Policy |
| 19 | Michigan Small Business Relief Program: Grants | Michigan Economic Development Corporation | Michigan Economic Development Corporation | Michigan Economic Development Corporation | https://www.michiganbusiness.org/495144/globalassets/documents/covid19/michigan-small-business-relief-program-grants_final.pdf | Provide up to $10 million in grant funding to one or more local economic development organizations or nonprofit economic development organizations to provide grants up to $10,000 to support certain small businesses statewide that have realized a significant financial hardship as a result of the COVID-19 outbreak. Amount per lead local economic development partner will be determined based on potential impact per region. | Funding $10 million, up to $10,000 | The company is in an industry outlined in Executive Order 2020-9, or any subsequent Executive Order of similar intent (“EO”), or demonstrates it is otherwise affected by the COVID-19 outbreak, that meets one or more of the following: provides support to impacted employees, is located in a downtown district or high impact corridor or has 50 employees or less, or is a company that provides services to companies outlined in the EO and requires additional employees to support to companies or employees impacted by EO; • The company has 50 employees or less; • The company needs working capital to support payroll expenses, rent, mortgage payments, utility expenses, or other similar expenses that occur in the ordinary course of business | unknown | |
| 20 | New York City Employee Retention Grant Program | Not Applicable | City of New York | New York | https://www1.nyc.gov/nycbusiness/article/nyc-employee-retention-grant-program | To help small businesses deal with the impact of COVID-19, the City has launched the Employee Retention Grant Program to help retain employees as businesses face decreased revenue | up to $27,000 | Businesses must be located in one of New York City’s five boroughs, have been operating for six months or more and have no current tax liens or legal judgments | Unknown | |
| 21 | Hillsboro Small Business Emergency Relief Program | Not applicable | City of Hillsboro, OR | Oregon | https://www.hillsboro-oregon.gov/our-city/covid-19/business-resources | offset losses associated with the coronavirus | $5,000 grant | Businesses with 10 or fewer employees will be prioritized | 3/20/2020 | Apps taken From March 23 to April 20 |
| 22 | ||||||||||
| 23 | Jade District-Old Town COVID-19 Small Business Response Fund | Not applicable | Asain Pacific American Network of Oregon | Oregon | https://www.apano.org/jade-district-covid-19-small-business-response-fund/ | Grants available to businesses that are affected by COVID-19 | Up to $190,000 total is available from local government sources | Small businesses located in the Jade District or Old Town Chinatown with a priority on Asian and Pacific Islander owned businesses. | 3/18/2020 | March 23: Applications due by 11:59 pm to covidsupport@apano.org |
| 24 | Amazon Neighborhood Small Business Relief Fund | Not applicable | Amazon | Washington | https://amazonsmallbusinessrelief.force.com/SelfRegisterPage | Amazon expects neighborhood small businesses will use these funds to cover day-to-day operating expenses and maintain their businesses. | $5 Million | Businesses in Bellevue, Wash. and the South Lake Union and Regrade neighborhoods of Seattle — particularly those that rely on foot traffic — can apply online for a grant from Amazon’s $5 million fund. Only businesses with 50 employees or less, or that take in less than $7 million in annual revenue, qualify | unknown | |
| 25 | State & Territorial Health Department Websites | Not applicable | CDC | United States | https://www.cdc.gov/publichealthgateway/healthdirectories/healthdepartments.html | You can reach various State DOH Website to find and search for more local economic resources | Varies | Varies | unknown | You can reach various State DOH Website to find and search for more local economic resources |
| 26 | IRS Relief for Taxpayers Affected by Ongoing Coronavirus Disease 2019 Pandemic | Not applicable | IRS | United States | https://www.irs.gov/pub/irs-drop/n-20-17.pdf | For an Affected Taxpayer, the due date for making Federal income tax payments due April 15, 2020, in an aggregate amount up to the Applicable Postponed Payment Amount, is postponed to July 15, 2020 |
Varies | The Secretary has determined that any person with a Federal income tax payment due April 15, 2020, is affected by the COVID-19 emergency | 3/17/2020 | |
| 27 | Philanthropy's response to the novel coronavirus (COVID-19). | Not applicable | Center for Disaster Philanthropy | United States | https://candid.org/explore-issues/coronavirus | Find which funders are supporting the response to coronavirus and what nonprofit business that funding is going. | 1.3 Million | Varies | Unknown | Candid is compiling a list of funds specifically established in the wake of coronavirus hosted at US-based foundations that serves, though others outside of this criteria may appear as well. To add to the list, please email coronavirus@candid.org. And to view resources available to individuals and small businesses, please visit our list on GrantSpace. |
| 28 | Facebook Small Business Grants Program | Not applicable | United States | https://www.facebook.com/business/boost/grants | Financial support for disruptions resulting from the global outbreak of COVID-19 | offering $100M in cash grants and ad credits to help during this challenging time | Facebook is offering $100M in cash grants and ad credits for up to 30,000 eligible small businesses in over 30 countries where we operate. We’ll share more details as they become available. | Unknown | ||
| 29 | United Way Worldwide COVID-19 Community Response and Recovery Fund | Not applicable | United Way | United States | https://www.unitedway.org/the-latest/press/united-way-worldwide-launches-covid-19-community-response-and-recovery-fund | Help the most vulnerable populations receive critical financial and social service support | Unknown | Varies | 3/17/2020 | |
| 30 | 211 | Not applicable | 211 | United States | http://211.org/services/covid19 | Assistance finding food, paying housing bills and accessing free childcare or other essential services | Varies | Individuals | Unknown | This site provides avilable several local sites and supports individuals. |
| 31 | Federal Economic Injury Disaster Loan Program | Not applicable | Small Business Association | United States | https://www.sba.gov/disaster-assistance/coronavirus-covid-19#section-header-1 | The SBA will work directly with state Governors to provide targeted, low-interest loans to small businesses and non-profits that have been severely impacted by the Coronavirus (COVID-19) | up to $2 million | In response to the Coronavirus (COVID-19) pandemic, small business owners in all U.S. states, Washington D.C., and territories are eligible to apply for an Economic Injury Disaster Loan advance | Varies | Applicants are encouraged to apply online for a disaster loan. If you do not have access to a computer or smartphone, please call us at 1‐800‐659‐2955 for assistance. |
| 32 | National Unemployment Benefits | Not applicable | DOL | United States | https://www.dol.gov/general/location | unemployment benefits for employees not able to work due to COVID-19 | Varies | If employees are temporarily laid off, have reduced hours, are told to isolate and quarantine due to a business downturn or closure as a result of COVID-19, they may be eligible for UC benefits. If employees are not receiving paid time off, they may be eligible for UC benefits. | Varies | This links to each state's unemployment assistance |
| 33 | Florida Small Business Emergency Bridge Loan | Not applicable | Florida Dept. of Economic Opportunity | Florida | http://www.floridadisasterloan.org/ | Provide an Emergency Bridge Loan for small businesses impacted by covid-19. Designed to bridge the gap to either federal SBA loans or commercially available loans. | Up to 50 Million | Small business business established prior to March 9 with two to 100 employees located in Florida affected by COVID-19 | 3/17/2020 | Closes 5/8/20 - For questions regarding the Emergency Bridge Loan Program, contact the Florida Small Business Development Center Network by calling 866-737-7232 or emailing |
| 34 | San Francisco COVID-19 Small Business Resiliency Fund | Not applicable | City of San Francisco | California | https://oewd.org/covid-19-small-business-resiliency-fund | It allows impacted small business owners to access up to $10,000 for employee salaries and rent | Up to 10,000 | To be eligible for the COVID-19 Small Businesses Resiliency Fund, small businesses must: Have at least 1 employee and no more than 5 employees Demonstrate a loss of revenue of 25% or more Have less than $2,500,000 in gross receipts Be engaged in activities that are regulated by the City and County of San Francisco and have a license/permit associated to that regulation |
unknown | |
| 35 | City of Los Angeles Small Business Emergency Microloan Program | Not applicable | City of Los Angeles | California | https://ewddlacity.com/index.php/microloan-program | Businesses and microenterprises in Los Angeles that are responsible for providing low-income jobs | $5,000 to $20,000 | To get a loan, you must meet requirements including having “reasonable and responsible” individual credit history, committing to use the loan for working capital only and ensuring your business is located within the City of Los Angeles. If you own 20% or more of the business, you must guarantee the loan. | 3/19/2020 | |
| 36 | Denver Small Business Emergency Relief | Not applicable | City of Denver, CO | Colorado | https://www.downtowndenver.com/newsroom/denver-small-business-emergency-relief-fund-announcement/ | This program offers cash grants of up to $7,500 to businesses in industries particularly hard-hit by the coronavirus. | up to $7,500 | Small businesses that have lost the ability to operate, including restaurants, retail shops, barbershops and nail salons. | Unknown | |
| 37 | Chicago Small Business Resiliency Fund | Not applicable | City of Chicago, IL | Illinios | https://www.connect2capital.com/partners/chicago-small-business-resiliency-fund/ | The City of Chicago recognizes that coronavirus disease (COVID-19) has put a difficult burden on our small business community. As a response to this challenge, the City is establishing a $100 million Chicago Small Business Resiliency Fund, which will help to provide small businesses with emergency cash flow during this immediate health crisis. Funds will be provided to eligible businesses as low-interest loans. | up to $50,000 | You must demonstrate a 25% drop in revenue, have less than $3 million in revenue and fewer than 50 employees, and have no current tax liens or legal judgments. | unkown | |
| 38 | Economic Injury Disaster Loans (EIDL) | Not applicable | Various | United States | https://covid19relief.sba.gov/#/ | Economic Relief due to affects of COVID-19 | Varies | Small Businesses, Non-profits, Tribal Businesses, and Cooperatives are eligible | Unknown | After applying, small businesses may be eligible for an up-front advance payment. This up-front advance payment does not have to be repaid. The full Economic Injury Disaster Loans are offered at a long-term, low-interest rate. |
| 39 | Public Health Crisis Response | CDC-RFA-TP18-1802 | CDC | United States | https://www.cdc.gov/cpr/readiness/funding-crisis.htm | Approved but Unfunded: CDC reviewed all 64 applications submitted in December from the 50 states, six large metropolitan areas, and eight U.S. territories and freely associated states. All that applied were deemed eligible through the Office of Grants Services’ eligibility review and the Office of Public Health Preparedness and Response’s (OPHPR) objective review process. In February 2018, CDC notified the jurisdictions that they are on CDC’s approved but unfunded (ABU) list of jurisdictions. This means CDC will consider these 64 jurisdictions for future funding if an emergency occurs and funding becomes available. | $569,822,380 | 50 states; five U.S. territories and three freely associated states; six localities: Chicago, Houston, Los Angeles County, New York City, Philadelphia, and Washington, D.C.; and federally recognized tribal governments that meet the NOFO requirements and serve, through their own public health infrastructures, at least 50,000 people. | Unknown | https://www.hhs.gov/about/news/2020/03/11/cdc-funding-information.html |
| 40 | Notice of Special Interest (NOSI) regarding the Availability of Emergency Competitive Revisions for Research on Severe Acute Respiratory Syndrome | NOT-AI-20-034 | National Institute of Allergy and Infectious Diseases (NIAID) | United States | https://grants.nih.gov/grants/guide/notice-files/NOT-AI-20-034.html | NIAID is issuing this Notice of Special Interest (NOSI) to highlight the need for research on Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19). NIAID is particularly interested in projects focusing on viral natural history, pathogenicity, transmission, as well as projects developing medical countermeasures and suitable animal models for pre-clinical testing of vaccines and therapeutics against SARS-CoV-2/COVID-19. | unknown | Applications in response to this NOSI must be submitted using the following targeted funding opportunity: PA-20-135; Emergency Competitive Revision to Existing NIH Awards (Emergency Supplement - Clinical Trial Optional), which is intended to provide funds for NIH grantees applying to expand the scope of their active grant. The funding instrument, or activity code, will be the same as the parent award. All activity codes of currently funded NIAID grants are eligible. Please note: NOT-AI-20-034 is specific for PA-20-135. NIH grantees seeking additional funds for research responsive to the SARS-CoV-2/COVID-19 outbreak that falls within the scope of an ongoing grant should instead apply for an administrative supplement under NIH PA-18-591, Administrative Supplements to Existing NIH Grants and Cooperative Agreements FOA (https://grants.nih.gov/grants/guide/pa-files/PA-18-591.html). |
March 25, 2020 | Related Announcements NOT-AI-20-040 PA-20-135; Emergency Competitive Revision to Existing NIH Awards (Emergency Supplement - Clinical Trial Optional) |
| 41 | Notice of Early Expiration of “Notice of Special Interest (NOSI) regarding the Availability of Urgent Competitive Revisions for Research on the 2019 | NOT-AI-20-040 | National Institute of Allergy and Infectious Diseases (NIAID) | United States | https://grants.nih.gov/grants/guide/notice-files/NOT-AI-20-040.html | The purpose of this Notice is to inform the extramural community that NOT-AI-20-030, “Notice of Special Interest (NOSI) regarding the Availability of Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus (2019-nCoV)” will be rescinded as of 04/08/2020 . NOT-AI-20-030 will be replaced by NOT-AI-20-034 for NIAID competitive revisions and NOT-GM-20-025 for NIGMS competitive revisions.NIAID will replace NOT-AI-20-030 with NOT-AI-20-034 which uses a different funding opportunity announcement, PA-20-135, “Emergency Competitive Revision to Existing NIH Awards (Clinical Trial Optional)” for competitive revision application submissions in response to the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) outbreak. NIAID applicants will have the option of applying to either NOT-AI-20-030 or NOT-AI-20-034 up until 04/08/2020 but are strongly encouraged to transition their application to NOT-AI-20-034 using the PA-20-135, “Emergency Competitive Revision to Existing NIH Awards (Clinical Trial Optional)” as soon as possible. However, NIAID will only accept applications to NOT-AI-20-034 after 04/08/2020. NIGMS will issue a new NOSI that will continue to use PA-18-935. NIGMS will replace NOT-AI-20-030 with NOT-GM-20-025 which will continue to receive competitive revision applications to PA-18-935 “Urgent Competitive Revision to Existing NIH Grants and Cooperative Agreements (Clinical Trial Optional)”. NIGMS’s new Notice includes additional areas of interest related to SARS-CoV-2 and COVID-19 and will allow support of competitive revisions above the established dollar limits for the parent grant award. Please see NOT-GM-20-025 for more information. NIGMS applicants will have the option of applying to either NOT-AI-20-030 or NOT-GM-20-025 up until 04/08/2020 but are strongly encouraged to transition their application to NOT-GM-20-025 as soon as possible. |
Not applicable | Not applicable | March 25, 2020 | |
| 42 | Notice of Special Interest (NOSI) regarding the Availability of Urgent Competitive Revisions for Research on Coronavirus Disease 2019 (COVID-19) and the Causative Virus SARS-CoV-2 | NOT-GM-20-025 | National Institute of General Medical Sciences (NIGMS) | United States | https://grants.nih.gov/grants/guide/notice-files/NOT-GM-20-025.html | NIGMS is issuing this Notice of Special Interest (NOSI) to highlight the urgent need for research on SARS-CoV-2 and Coronavirus Disease 2019 (COVID-19). | Not applicable | Applications in response to this NOSI must be submitted to PA-18-935 "Urgent Competitive Revision to Existing NIH Grants and Cooperative Agreements (Urgent Supplement - Clinical Trial Optional)", which is intended to provide funds for NIH grantees applying to expand the scope of their active grant. The activity code will be the same as that of the parent award. Competitive revision applications to PA-18-935 must use the application form package with the Competition ID of “NOT-GM-20-025-FORMS-E." This FOA will be reissued with a “NOT-GM-20-025-FORMS-F” package on May 25, 2020. Submissions to PA-18-935 must be completed by June 25, 2020. Submissions to the reissued FOA will be accepted on or after May 25, 2020 through the expiration date of this Notice. Applications will be accepted on a rolling basis from March 25, 2020 to February 5, 2021 by 5:00 PM local time of the applicant organization. This NOSI expires on February 6, 2021 . An application submitted in response to this NOSI that is received on/after the expiration date will be withdrawn. |
March 25, 2020 | Expiration Date: February 06, 2021 |
| 43 | Notice of Special Interest (NOSI) regarding the Availability of Urgent Competitive Revisions for Research on Coronavirus Disease 2019 (COVID-19) and the Causative Virus SARS-CoV-2 | NOT-GM-20-025 | National Institute of General Medical Sciences (NIGMS) | United States | https://grants.nih.gov/grants/guide/notice-files/NOT-GM-20-025.html | NIGMS is issuing this Notice of Special Interest (NOSI) to highlight the urgent need for research on SARS-CoV-2 and Coronavirus Disease 2019 (COVID-19). | Not applicable | Applications in response to this NOSI must be submitted to PA-18-935 "Urgent Competitive Revision to Existing NIH Grants and Cooperative Agreements (Urgent Supplement - Clinical Trial Optional)", which is intended to provide funds for NIH grantees applying to expand the scope of their active grant. The activity code will be the same as that of the parent award. Competitive revision applications to PA-18-935 must use the application form package with the Competition ID of “NOT-GM-20-025-FORMS-E." This FOA will be reissued with a “NOT-GM-20-025-FORMS-F” package on May 25, 2020. Submissions to PA-18-935 must be completed by June 25, 2020. Submissions to the reissued FOA will be accepted on or after May 25, 2020 through the expiration date of this Notice. Applications will be accepted on a rolling basis from March 25, 2020 to February 5, 2021 by 5:00 PM local time of the applicant organization. This NOSI expires on February 6, 2021 . An application submitted in response to this NOSI that is received on/after the expiration date will be withdrawn. |
March 25, 2020 | |
| 44 | Notice of Special Interest (NOSI) regarding the Availability of Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus (2019-nCoV) | NOT-AI-20-030 | National Institute of Allergy and Infectious Diseases (NIAID) National Institute of General Medical Sciences (NIGMS) | United States | https://grants.nih.gov/grants/guide/notice-files/NOT-AI-20-030.html | NIAID and NIGMS are issuing this Notice of Special Interest (NOSI) to highlight the urgent need for research on the 2019 novel Coronavirus (2019-nCoV). NIAID is particularly interested in projects focusing on viral natural history, pathogenicity, transmission, as well as projects developing medical countermeasures and suitable animal models for pre-clinical testing of vaccines and therapeutics against 2019-nCoV. NIGMS is specifically interested in incorporation of data from the 2019-nCoV into ongoing research efforts to develop predictive models for the spread of Coronaviruses and related pathogens. NIAID and NIGMS are therefore offering Competitive Revisions to active grants addressing research objectives described below. |
Not applicable | Applications in response to this NOSI must be submitted using the following targeted funding opportunity: PA-18-935 Urgent Competitive Revision to Existing NIH Grants and Cooperative Agreements (Urgent Supplement - Clinical Trial Optional), which is intended to provide funds for NIH grantees applying to expand the scope of their active grant. Further details can be found here: https://www.niaid.nih.gov/grants-contracts/urgent-award-mechanism.. The funding instrument, or activity code, will be the same as the parent award. Please note:NOT-AI-20-030 is specific for PA-18-935. NIH grantees seeking additional funds for research responsive to the 2019-nCoV outbreak that falls within the scope of an ongoing grant should instead apply for an administrative supplement under NIH PA-18-591, Administrative Supplements to Existing NIH Grants and Cooperative Agreements FOA (https://grants.nih.gov/grants/guide/pa-files/PA-18-591.html). |
February 6, 2020 | Expiration Date: April 8, 2020 |
| 45 | Notice of Special Interest (NOSI): Availability of Administrative Supplements and Revision Supplements on Coronavirus Disease 2019 (COVID-19) | NOT-HL-20-757 | National Heart, Lung, and Blood Institute (NHLBI) | United States | https://grants.nih.gov/grants/guide/notice-files/NOT-HL-20-757.html | NHLBI is issuing this Notice of Special Interest (NOSI) to highlight the urgent need for research on Coronavirus Disease 2019 (COVID-19) and on biological effects of its causative agent, the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Topics of specific interest to NHLBI include host response, associations with heart, lung, and blood (HLB) diseases, potential impacts on transfusion safety, and clinical outcomes of infected individuals. | Not applicable | Investigators planning to submit an application in response to this NOSI are strongly encouraged to contact and discuss their proposed research/aims with Program staff listed on this NOSI well in advance of the grant receipt date to better determine appropriateness and interest of the NHLBI. | March 17, 2020 | Expiration Date: October 06, 2020 |
| 46 | Notice of Special Interest (NOSI) regarding the Availability of Administrative Supplements and Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus | NOT-DA-20-047 | National Institute on Drug Abuse (NIDA) | United States | https://grants.nih.gov/grants/guide/notice-files/NOT-DA-20-047.html | NIDA is issuing this Notice of Special Interest (NOSI) to highlight the urgent need for research on the 2019 Novel Coronavirus (2019-nCoV, also known as COVID-19). NIDA is especially interested in research collecting and examining data on the risks and outcomes for COVID-19 infection in individuals suffering from substance use disorders. | Not applicable | Applications in response to this NOSI must be submitted using the following targeted funding opportunity: PA-18-935 Urgent Competitive Revision to Existing NIH Grants and Cooperative Agreements (Urgent Supplement - Clinical Trial Optional) is intended to provide funds for NIH grantees applying to expand the scope of their active grant. PA-18-591 Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp Clinical Trial Optional) is intended to provide funds for NIH grantees where the work proposed in the supplement is fully within the scope of the ongoing grant. The funding instrument, or activity code, will be the same as the parent award. |
March 19, 2020 | Expiration Date: March 31, 2021 |
| 47 | Notice of Special Interest (NOSI) Clinical and Translational Science Award (CTSA) Program Applications to Address 2019 Novel Coronavirus (COVID-19) Public Health Need | NOT-TR-20-011 | National Center for Advancing Translational Sciences (NCATS) | United States | https://grants.nih.gov/grants/guide/notice-files/NOT-TR-20-011.html | National Center for Advancing Translational Sciences (NCATS) is issuing this Notice of Special Interest (NOSI) to highlight the urgent need for research on the 2019 novel Coronavirus (COVID-19). NCATS is particularly interested in projects focusing on the use of informatics solutions to diagnose cases and the use of CTSA-supported core resources (e.g., advanced scientific instruments, highly-specialized facilities, and regulatory expertise) to facilitate research on COVID-19 and advance the translation of research findings into diagnostics, therapeutics, and vaccines. NCATS is soliciting applications for Administrative Supplements to UL1, U01, and R21 awards (through PA-18-591), Collaborative Innovation Awards to U01 and R21 awards (through PAR-19-099 and PAR-19-100, respectively), and Competitive Revisions for UL1 awards for each of the non-administrative supplement awards (through PAR-19-337). | Not applicable | March 24, 2020 | Expiration Date: July 10, 2021 | |
| 48 | Notice of Special Interest (NOSI) regarding the Availability of Urgent Competitive Revisions for Research on Coronavirus Disease 2019 (COVID-19) and the Causative Virus SARS-CoV-2 | NOT-GM-20-025 | National Institute of General Medical Sciences (NIGMS) | United States | https://grants.nih.gov/grants/guide/notice-files/NOT-GM-20-025.html | NIGMS is issuing this Notice of Special Interest (NOSI) to highlight the urgent need for research on SARS-CoV-2 and Coronavirus Disease 2019 (COVID-19). | Not applicable | March 25, 2020 | Expiration Date: February 06, 2021 | |
| 49 | Notice of Special Interest (NOSI) regarding the Availability of Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus (2019-nCoV) | NOT-AI-20-030 | National Institute of Allergy and Infectious Diseases (NIAID) National Institute of General Medical Sciences (NIGMS) | United States | https://grants.nih.gov/grants/guide/notice-files/NOT-AI-20-030.html | NIAID and NIGMS are issuing this Notice of Special Interest (NOSI) to highlight the urgent need for research on the 2019 novel Coronavirus (2019-nCoV). NIAID is particularly interested in projects focusing on viral natural history, pathogenicity, transmission, as well as projects developing medical countermeasures and suitable animal models for pre-clinical testing of vaccines and therapeutics against 2019-nCoV. NIGMS is specifically interested in incorporation of data from the 2019-nCoV into ongoing research efforts to develop predictive models for the spread of Coronaviruses and related pathogens. NIAID and NIGMS are therefore offering Competitive Revisions to active grants addressing research objectives described below. |
February 6, 2020 | Expiration Date: April 8, 2020 | ||
| 50 | Notice of Special Interest: NIEHS Worker Training Program Coronavirus and Infectious Disease Response Training (Admin Supp Clinical Trial Not Allowed) | NOT-ES-20-014 | National Institute of Environmental Health Sciences (NIEHS) | United States | https://grants.nih.gov/grants/guide/notice-files/NOT-ES-20-014.html | The purpose of this supplement is to provide support for the conduct of worker-based training to prevent and reduce exposure of hospital employees, emergency first responders, and other workers who are at risk of exposure to Coronavirus through their work duties. The NIEHS Superfund Worker Training Program (WTP) will work collaboratively to develop and target safety and health training for those workers supporting the national Coronavirus response. Using our hazmat trainers’ understanding of worker safety and health protection issues, knowledge of personal protective equipment (PPE) usage, and experience in training disaster workers, WTP will coordinate with the Centers for Disease Control and Prevention (CDC), the Occupational Safety and Health Administration (OSHA), and the National Institute for Occupational Safety and Health (NIOSH) to provide awardees with material to develop an evidence-based curriculum that addresses the science of Coronavirus (clinical symptoms, mode of transmission, persistence in the environment, and treatment); infection control and worker protection (isolation/quarantine and PPE); working in the contaminated environment (sampling and decontamination); and behavioral health resiliency . The funding for this supplement is provided from the Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020. This Notice of Special Interest (NOSI) requests applications for FY 2020 administrative supplements to provide support to conduct worker-based training to prevent and reduce exposure of hospital employees, emergency first responders, and other workers who are at risk of exposure to Coronavirus through their work duties. Under the Infectious Disease Response (IDR) program the WTP implemented an infectious disease response training for workers across sectors who may be exposed to infectious diseases. The program, funded under RFA-ES-15-018 began June 1, 2016, and ran through May 31, 2019 and built federal capacity for biosecurity, biopreparedness, and rapid response to emerging infectious diseases, including developing an infrastructure of trainers and organizations who can be a resource during emergencies. As of May 31, 2019, program grantees delivered approximately 1,700 courses to 36,000 workers, with more than 145,000 contact hours. In-person trainings occurred in 36 states and one territory. A Pathogen Safety Data course was created and piloted to improve workers' health literacy and empower them to perform job hazard analysis on specific pathogens allowing them to mitigate or reduce their exposure while performing their assigned duties. NIEHS WTP program has over 30 years of experience providing workers health and safety training related to potential exposures to biological hazards as they perform their job duties. Many of the training courses provided by WTP grantees are based off of OSHA’s Bloodborne Pathogens standard (29 CFR 1910.1030 (https://www.osha.gov/laws-regs/regulations/standardnumber/1910/1910.1030)), OSHA’s Respirator Protection standard (29 CFR 1910.134 (https://www.osha.gov/pls/oshaweb/owadisp.show_document?p_table=STANDARDS&p_id=12716)), OSHA’s Personal Protective Equipment (PPE) standard (29 CFR 1910.132 (https://www.osha.gov/pls/oshaweb/owadisp.show_document?p_table=STANDARDS&p_id=9777)) and Section 5(a)(1) of the Occupational Safety and Health (OSH) Act of 1970 (https://www.osha.gov/laws-regs/oshact/section5-duties), often referred to as the General Duty Clause, and OSHA Best Practices for Hospital-Based First Receivers of Victims (https://www.osha.gov/dts/osta/bestpractices/firstreceivers_hospital.html). WTP grantees have been involved in providing biosafety health and safety training to workers during the H5N1 outbreak, the 2001 Anthrax attacks, the H1N1 Avian Influenza 2009, mold remediation from Hurricanes Katrina and Sandy, to Ebola starting in 2013. Their audiences have spanned the worker population from healthcare workers to volunteers. Currently, NIEHS WTP grantees are re-programming existing extramural funds to provide Coronavirus preparedness training to their worker populations. The newly proposed training under this announcement would be utilized to award supplemental funding to expand these ongoing Coronavirus response training efforts. |
Not applicable | Applicants must be an active grantee of RFA-ES-19-003, "Hazardous Materials Worker Health and Safety Training (U45 Clinical Trials Not Allowed)", RFA-ES-19-004, "HAZMAT Training at DOE Nuclear Weapons Complex (UH4 Clinical Trial Not Allowed)" , RFA-ES-15-018, "Worker Training Program (WTP) Ebola Biosafety and Infectious Disease Response Training (UH4)", or RFA-ES-19-009 - SBIR E-Learning for HAZMAT and Emergency Response (R43/R44 Clinical Trial Not Allowed). | March 27, 2020 | |
| 51 | Notice of Special Interest (NOSI): Repurposing Existing Therapeutics to Address the 2019 Novel Coronavirus Disease (COVID-19) | NOT-TR-20-012 | National Center for Advancing Translational Sciences (NCATS) | United States | https://grants.nih.gov/policy/natural-disasters/corona-virus.htm | National Center for Advancing Translational Sciences (NCATS) is issuing this Notice of Special Interest (NOSI) to highlight the urgent need for research on the 2019 novel coronavirus (SARS-CoV-2) and the disease it causes, i.e., “coronavirus disease 2019” (COVID-19). NCATS is particularly interested in projects that repurpose existing drugs or biologics (existing therapeutics) that have already begun or completed a Phase I clinical trial. The hypothesis for proposed studies must be developed using innovative processes to identify the therapeutic/indication pair. Examples include the following: Testing a publicly posted therapeutic candidate for use to treat COVID-19. Examples include clinical candidate therapeutics in documents publicly posted by the World Health Organization (types/classes of candidate therapeutics) and (candidates for clinical evaluation). Testing a candidate therapy to treat COVID-19 that was already identified with a publicly available computational approach. Testing of existing therapeutic candidates that work on mechanistic targets shared among other viruses that may be relevant to SARS-CoV-2. NCATS is soliciting applications to PAR-17-465, PAR-18-462, and PAR-18-332. |
Not applicable | March 27, 2020 | First Available Due Date: June 05, 2020 Expiration Date: October 17, 2020 |
|
| 52 | Notice of Special Interest (NOSI) regarding the Availability of Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus | NOT-HG-20-030 | National Human Genome Research Institute (NHGRI) | https://grants.nih.gov/grants/guide/notice-files/NOT-HG-20-030.html | Background As of March 27, 2020, more than 565,000 cases of COVID-19 and 25,000 deaths have been reported worldwide, with more than 92,000 cases and 1,300 deaths in the United States. The severity of illness and course of the infection is heterogenous and appears to be more severe in the elderly and in individuals with underlying comorbidities. To date, SARS-CoV-2 and COVID-19 disease has not caused significant morbidity in infancy and early childhood, a pattern atypical for most viral respiratory diseases. Genomic studies can help inform efforts to prevent, diagnose and treat viral respiratory diseases. Research Objectives A better understanding of the host response, associated disease, and short- and long-term clinical outcomes of individuals infected with SARS-CoV-2. For NHGRI grantees only (including those with a current extension of funds or a no cost extension), we encourage the submission of applications for Competitive Revisions to support genomic research on SARS-CoV-2 and COVID-19 disease. Of particular interest are genomic studies utilizing generalized approaches that take advantage of human research or model systems to study the consequences of SARS-CoV-2 infection. Supported research is expected to guide and inform future efforts to diagnose, prevent, mitigate, or treat this viral infection. Possible research interests include but are not limited to the following: Develop novel methods using genomic techniques to identify signatures of infection, prognosis, and/or severity of disease in a medical setting. Development of novel genomic-based tools, kits or reagents to track and monitor SARS-CoV-2 itself and infected individuals. Computational approaches to integrate human or animal model genomic data with data from SARS-CoV-2 infection, replication, pathogenesis and transmission to inform models of host-pathogen interactions and predict infection outcomes. Development of visualization, curation and analysis platforms for human and animal model genomic data related to SARS-CoV-2 infection, replication, pathogenesis and transmission studies. Use of electronic health information, or other relevant clinical, environmental, demographic and social determinants of health data, and accompanying genomic data to aid in tracking and understanding the genetic epidemiology of SARS-CoV-2, and the individual susceptibility and resistance to infection and disease severity. Studies addressing the ethical, legal and social implications of the use of genetic and genomic information and technologies to diagnose, track, monitor, treat and triage SARS-CoV-2 and COVID-19 infected patients and populations in clinical and public health settings. Funds may be used for the collection of samples from human cohorts of individuals with COVID-19 symptoms or evidence of SARS-CoV-2 infection or controls, and/or development of novel model systems to expose animals and cells to SARS-CoV-2. |
Not applicable | Investigators planning to submit an application in response to this NOSI are strongly encouraged to contact and discuss their proposed research/aims with Program staff listed on this NOSI well in advance of the grant receipt date to better determine appropriateness and interest of the NHGRI. | March 31, 2020 | ||
| 53 | The Urbanized Area Formula Funding program | 49 U.S.C. 5307 | Federal Transit Administration | United States | https://www.transit.dot.gov/funding/grants/urbanized-area-formula-grants-5307 | The Urbanized Area Formula Funding program (49 U.S.C. 5307) makes federal resources available to urbanized areas and to governors for transit capital and operating assistance in urbanized areas and for transportation-related planning. | Varies | Funding is made available to designated recipients that are public bodies with the legal authority to receive and dispense federal funds. Governors, responsible local officials and publicly owned operators of transit services shall designate a recipient to apply for, receive, and dispense funds for urbanized areas pursuant to 49USCA5307(a)(2). The governor or governor's designee acts as the designated recipient for urbanized areas between 50,000 and 200,000. For urbanized areas with 200,000 in population and over, funds are apportioned and flow directly to a designated recipient selected locally to apply for and receive Federal funds. For urbanized areas under 200,000 in population, the funds are apportioned to the governor of each state for distribution. |
Unknown | |
| 54 | Formula Grants for Rural Areas | 49 U.S.C. Chapter 53, Section 5311 | Federal Transit Administration | United States | https://www.transit.dot.gov/funding/grants/formula-grants-rural-areas-fact-sheet-section-5311 | The Formula Grants for Rural Areas program provides capital, planning, and operating assistance to states and federally recognized Indian tribes to support public transportation in rural areas with populations less than 50,000. | Varies | Eligible Recipients: • States, Indian tribes or Alaskan Native villages, groups or communities identified by the Bureau of Indian Affairs (BIA) • Subrecipients: State or local government authorities, nonprofit organizations, operators of public transportation or intercity bus service that receives funds indirectly through a recipient. |
Unknown | |
| 55 | State of Good Repair Grants | 49 U.S.C. 5337 | Federal Transit Administration | United States | https://www.transit.dot.gov/funding/grants/state-good-repair-grants-5337 | Eligible recipients are state and local government authorities in UZAs with fixed guideway and high intensity motorbus systems in revenue service for at least seven years. | Not Applicable | State of Good Repair Grants funds are available for capital projects that maintain a fixed guideway or a high intensity motorbus system in a state of good repair, including projects to replace and rehabilitate: rolling stock track line equipment and structures signals and communications power equipment and substations passenger stations and terminals security equipment and systems maintenance facilities and equipment operational support equipment, including computer hardware and software; as well as implement transit asset management plans. |
Unknown | |
| 56 | The Section 5340 Growing States/High Density States Program | 5340 | Federal Transit Administration | United | https://www.transit.dot.gov/funding/grants/section-5340-growing-stateshigh-density-states-program-pdf | unknown | unknown | unknown | unknown | |
| 57 | Google Ad Grants | Not applicable | United States | https://blog.google/inside-google/company-announcements/commitment-support-small-businesses-and-crisis-response-covid-19 | $250 million in ad grants to help the World Health Organization (WHO) and more than 100 government agencies globally provide critical information on how to prevent the spread of COVID-19 and other measures to help local communities. In addition, we’re providing $20 million in ad grants to community financial institutions and NGOs specifically to run public service announcements on relief funds and other resources for SMBs. | $250 million | unknown | 3/27/2020 |